The TIGAR (TP53-Induced Glycolysis and Apoptosis Regulator) gene encodes a crucial metabolic enzyme that plays dual roles in cellular energy metabolism and apoptosis regulation. Originally identified as a p53 target gene, TIGAR functions as a fructose-2,6-bisphosphatase that regulates glycolysis and the pentose phosphate pathway, thereby influencing cellular survival under conditions of metabolic stress and oxidative damage. The gene is located on chromosome 12p12.3 and has emerged as an important player in understanding the intersection between metabolism and neurodegeneration.
| Property | Value |
|---|---|
| Gene Symbol | TIGAR |
| Full Name | TP53-Induced Glycolysis and Apoptosis Regulator |
| Synonyms | C12orf5, FRPW1, TIGAR |
| Chromosomal Location | 12p12.3 |
| NCBI Gene ID | 2063 |
| UniProt ID | Q96PX8 |
| Protein Length | 270 amino acids |
| Molecular Weight | ~30 kDa |
The TIGAR gene spans approximately 25 kb on chromosome 12p12.3 and contains 8 exons. The gene is transcribed from a promoter region that contains functional p53 binding sites, making it a direct transcriptional target of the tumor suppressor p53. The gene is evolutionarily conserved across mammals, reflecting its fundamental role in cellular metabolism.
The TIGAR protein contains several functional domains:
Fructose-2,6-bisphosphatase domain: The central catalytic domain that hydrolyzes fructose-2,6-bisphosphate (F2,6BP), a potent allosteric activator of phosphofructokinase-1 (PFK-1). This activity is the key metabolic function of TIGAR.
N-terminal domain: Contains regulatory sequences that control enzyme activity and subcellular localization.
C-terminal region: Mediates protein-protein interactions and may participate in localization to specific cellular compartments.
The protein localizes to both the cytoplasm and nucleus, with its localization influencing its function. Nuclear localization has been associated with roles in DNA damage responses, while cytoplasmic functions relate to metabolic regulation.
TIGAR serves as a major regulator of carbohydrate metabolism through its enzymatic activity:
Fructose-2,6-bisphosphatase activity:
TIGAR hydrolyzes fructose-2,6-bisphosphate (F2,6BP), reducing glycolytic flux. This activity has several important consequences:
Pentose phosphate pathway activation:
By reducing F2,6BP levels, TIGAR promotes flux through the pentose phosphate pathway (PPP), which generates:
This metabolic reprogramming is particularly important under conditions of oxidative stress, where NADPH is needed for maintaining the reduced glutathione pool and countering reactive oxygen species.
TIGAR was originally named for its role in apoptosis regulation through p53-dependent pathways:
Pro-survival functions:
Cell death modulation:
The relationship between TIGAR and apoptosis is context-dependent:
TIGAR has emerged as an important player in Parkinson's disease pathogenesis:
Dopaminergic neuron survival:
Research by Green et al. (2019) demonstrated that TIGAR deficiency sensitizes dopaminergic neurons to cell death in models of Parkinson's disease. Loss of TIGAR function leads to:
Mitochondrial protection:
Li et al. (2020) showed that TIGAR protects dopaminergic neurons from mitochondrial toxins through its metabolic regulatory functions. The mechanism involves:
Alpha-synuclein toxicity:
Park et al. (2019) discovered that TIGAR knockdown exacerbates alpha-synuclein toxicity, linking this metabolic regulator to the core pathological feature of Parkinson's disease. This suggests that TIGAR dysfunction may contribute to disease progression.
TIGAR's role in Alzheimer's disease relates to its metabolic and antioxidant functions:
Metabolic dysfunction:
Kim et al. (2019) demonstrated altered TIGAR expression in Alzheimer's disease brain, suggesting involvement in the metabolic dysfunction characteristic of AD. The changes may contribute to:
Oxidative stress protection:
Hoshino et al. (2019) showed that TIGAR protects against oxidative stress-induced cell death, a key mechanism in AD pathogenesis. The enzyme's ability to generate NADPH supports cellular antioxidant defenses.
TIGAR may play roles in other neurodegenerative diseases:
Amyotrophic lateral sclerosis (ALS):
The metabolic regulatory functions of TIGAR could influence motor neuron survival under conditions of oxidative stress.
Huntington's disease:
TIGAR's PPP activation and NADPH generation may be relevant to the metabolic dysfunction observed in Huntington's disease.
Stroke and ischemic injury:
TIGAR's metabolic functions could influence neuronal survival following cerebral ischemia, where metabolic stress and oxidative damage are key players.
TIGAR is a canonical p53 target gene:
The p53-TIGAR axis represents an important link between cellular stress responses and metabolic regulation.
TIGAR interacts with multiple metabolic pathways:
Glycolysis:
Pentose phosphate pathway:
Mitochondrial metabolism:
Antioxidant systems:
TIGAR interacts with several proteins relevant to neurodegeneration:
Modulating TIGAR activity represents a potential therapeutic approach:
Activation strategies:
Inhibition strategies:
Cell-type specificity:
TIGAR functions differ across cell types, requiring cell-type-specific targeting approaches.
Context-dependent effects:
The role of TIGAR in survival versus death depends on the specific cellular context and stress conditions.
BBB delivery:
Therapeutic targeting of brain TIGAR requires overcoming the blood-brain barrier.
Key methods for studying TIGAR include: